Astal Laboratories Ltd — Important, 01-01-2026: Company Update

Astal Laboratories has received in-principle approval from BSE for its proposed preferential issue of 3,04,25,632 equity shares. These shares, with a face value of Rs. 10 each, will be issued to non-promoters at a price not less than Rs. 91 per share, part of a share swap arrangement. This approval is a crucial step towards expanding the company's equity base and facilitating a strategic share swap, potentially valued at over 276.87 Cr. This move could support future growth and operational strategies.